drugset / Trial / NCT06792344
Clinical Study of CD19 CAR-T in the Treatment of Refractory Systemic Sclerosis
Phase 1
Suspended
12 enrolled
The Children's Hospital of Zhejiang University School of Medicine
Guangzhou Women and Children's Medical Center · collab
NaSingle-groupOpen-labelTreatment
Summary
This is an investigator-initiated trial aimed at assessing the safety and efficacy of anti-CD19 CAR-T cells in the treatment of childhood-onset systemic sclerosis
Timeline
- Start
- 2025-12-14
- Primary completion
- 2027-12-14
- Completion
- 2028-12-31
Outcome
Outcome not reported
Stopped: “temporarily suspended due to no new subjects at present”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | anti-CD19 CAR-T cells | Cell therapy | — | Intravenous |